Initial Antiretroviral Third-Drug Class and Time to Loss of Virologic Suppression: A Real-World Colombian Cohort Study.

Alzate-Ángel JC, Sussmann O, Andrade J, Hernández B, Mueses-Marín H, Galindo X, Valderrama-Beltrán SL, Lenis W, Montero L, Mantilla M, Arévalo L, Alzamora D, Delgado E, García M, Martínez-Buitrago E, VIHCOL Group

Open source

DOI: 10.1177/23259582261436966
Published: 2026 Jan-Dec
Container: Journal of the International Association of Providers of AIDS Care
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/23259582261436966,
  title = {Initial Antiretroviral Third-Drug Class and Time to Loss of Virologic Suppression: A Real-World Colombian Cohort Study.},
  author = {Alzate-Ángel JC and Sussmann O and Andrade J and Hernández B and Mueses-Marín H and Galindo X and Valderrama-Beltrán SL and Lenis W and Montero L and Mantilla M and Arévalo L and Alzamora D and Delgado E and García M and Martínez-Buitrago E and VIHCOL Group},
  year = {2026},
  journal = {Journal of the International Association of Providers of AIDS Care},
  doi = {10.1177/23259582261436966},
  url = {https://doi.org/10.1177/23259582261436966}
}

RIS

TY  - JOUR
TI  - Initial Antiretroviral Third-Drug Class and Time to Loss of Virologic Suppression: A Real-World Colombian Cohort Study.
AU  - Alzate-Ángel JC
AU  - Sussmann O
AU  - Andrade J
AU  - Hernández B
AU  - Mueses-Marín H
AU  - Galindo X
AU  - Valderrama-Beltrán SL
AU  - Lenis W
AU  - Montero L
AU  - Mantilla M
AU  - Arévalo L
AU  - Alzamora D
AU  - Delgado E
AU  - García M
AU  - Martínez-Buitrago E
AU  - VIHCOL Group
PY  - 2026
JO  - Journal of the International Association of Providers of AIDS Care
DO  - 10.1177/23259582261436966
UR  - https://doi.org/10.1177/23259582261436966
ER  -

APA

JC, A., O, S., J, A., B, H., H, M., X, G., SL, V., W, L., L, M., M, M., L, A., D, A., E, D., M, G., E, M., & Group, V. (2026). Initial Antiretroviral Third-Drug Class and Time to Loss of Virologic Suppression: A Real-World Colombian Cohort Study.. Journal of the International Association of Providers of AIDS Care. https://doi.org/10.1177/23259582261436966

Source records

pubmed · retrieved 2026-09-27T01:14:27.932Z